GlassScriptPhysician profile
David Klatz
NPI 1891219945
$6,239.20
in general payments reported to CMS, 2019-2025
16 companies · $956 in 2025
The $956 reported for 2025 was more than what 90% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $491 · 2020: $187 · 2021: $711 · 2022: $1,242 · 2023: $1,137 · 2024: $1,516 · 2025: $956.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,591 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,590.82 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $3,280.89 | 2022-2025 | Infuse, Biotrue, Lenscrafters |
| Alcon Vision LLC | $892.54 | 2019-2025 | Total30, Dailies Total1, Precision 1 |
| Johnson & Johnson Vision Care, INC. | $674.07 | 2019-2025 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $618.26 | 2019-2021 | |
| Allergan, INC. | $146.22 | 2021-2022 | |
| Tarsus Pharmaceuticals, INC. | $121.21 | 2024 | Xdemvy |
| Abbvie INC. | $121.12 | 2022 | |
| Rxsight INC | $99.03 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Coopervision INC. | $88.38 | 2019-2023 | Misight Contact Lens |
| Novartis Pharmaceuticals Corporation | $75.94 | 2019-2022 | |
| Glaxosmithkline, LLC. | $44.99 | 2023 | Shingrix, Arexvy |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Abb Con-Cise Optical Group LLC | $15.99 | 2019 | |
| Maculogix, INC. | $14.64 | 2020 | |
| Oyster Point Pharma, INC. | $14.39 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $14.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Klatz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.